Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 88 results.
User Information
Export Records
  1. 1.   Design of soluble HIV-1 envelope trimers free of covalent gp120-gp41 bonds with prevalent native-like conformation
  2. Zhang, Peng; Gorman, Jason; Tsybovsky,Yaroslav; Lu, Maolin; Liu, Qingbo; Gopan, Vinay; Singh, Mamta; Lin, Yin; Miao, Huiyi; Seo, Yuna; Kwon, Alice; Olia, Adam S; Chuang, Gwo-Yu; Geng, Hui; Lai, Yen-Ting; Zhou, Tongqing; Mascola, John R; Mothes, Walther; Kwong, Peter D; Lusso, Paolo
  3. Cell Reports. 2024, Jul 18; 43(8): 114518.
  1. 2.   Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors
  2. Kundu, Biswajit; Dvorácskó, Szabolcs; Basu, Abhishek; Pommerolle, Lenny; Kim, Kyu Ah; Wood, Casey M; Gibbs, Eve; Behee, Madeline; Tarasova,Nadya; Cinar, Resat; Iyer, Malliga R
  3. Molecules (Basel, Switzerland). 2024, Jun 26; 29(13):
  1. 3.   Soluble form of the MDA5 protein in human sera
  2. Okamoto, Masaki; Zaizen, Yoshiaki; Kaieda, Shinjiro; Nouno, Takashi; Koga, Takuma; Matama, Goushi; Mitsuoka, Masahiro; Akiba, Jun; Yamada, Shintaro; Kato, Hiroki; Hoshino,Tomoaki
  3. Heliyon. 2024, Jun 15; 10(11): e31727.
  1. 4.   Co-Isolation of Cytokines and Exosomes: Implications for Immunomodulation Studies
  2. Benjamin-Davalos, Shawna; Koroleva, Marina; Allen, Cheryl L.; Ernstoff, Marc S.; La Shu, Shin
  3. Frontiers In Immunology. 2021, Apr 19; 12
  1. 5.   Molecular dynamics based improvement of the solubilizing self-cleavable tag Zbasic-?I-CM application in the preparation of recombinant proteins in Escherichia coli
  2. Luo, Han; Hu, Lifu; Ma,Buyong; Zhao, Meiqi; Luo, Manyu; Deng, Qing; Deng, Shaorong; Ye, Hao; Lin, Tong; Chen, Junsheng; Wang, Tao; Zhu, Jianwei; Lu, Huili
  3. Biochemical and biophysical research communications. 2019, MAY 28; 513(2): 412-418.
  1. 6.   JS-K, a Glutathione S-Transferase-Activated Nitric Oxide Donor With Antineoplastic Activity in Malignant Gliomas
  2. Weyerbrock, A.; Osterberg, N.; Psarras, N.; Baumer, B.; Kogias, E.; Werres, A.; Bette, S.; Saavedra, J. E.; Keefer, L. K.; Papazoglou, A.
  3. Neurosurgery. 2012, Feb; 70(2): 497-510.
  1. 7.   IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization
  2. Han, K. P.; Zhu, X. Y.; Liu, B.; Jeng, E.; Kong, L.; Yovandich, J. L.; Vyas, V. V.; Marcus, W. D.; Chavaillaz, P. A.; Romero, C. A.; Rhode, P. R.; Wong, H. C.
  3. Cytokine. 2011, Dec; 56(3): 804-810.
  1. 8.   Engineered Single Human CD4 Domains as Potent HIV-1 Inhibitors and Components of Vaccine Immunogens
  2. Chen, W. Z.; Feng, Y.; Gong, R.; Zhu, Z. Y.; Wang, Y. P.; Zhao, Q.; Dimitrov, D. S.
  3. Journal of Virology. 2011, Sep; 85(18): 9395-9405.
  1. 9.   Prediagnostic Serum Levels of Cytokines and Other Immune Markers and Risk of Non-Hodgkin Lymphoma
  2. Purdue, M. P.; Lan, Q.; Bagni, R.; Hocking, W. G.; Baris, D.; Reding, D. J.; Rothman, N.
  3. Cancer Research. 2011, Jul; 71(14): 4898-4907.
  1. 10.   New monoterpene glycosides and phenolic compounds from Distylium racemosum and their inhibitory activity against ribonuclease H
  2. Kim, J. A.; Yang, S. Y.; Wamiru, A.; McMahon, J. B.; Le Grice, S. F. J.; Beutler, J. A.; Kim, Y. H.
  3. Bioorganic & Medicinal Chemistry Letters. 2011, May; 21(10): 2840-2844.
  1. 11.   Magnetic resonance imaging of organic contrast agents in mice: capturing the whole-body redox landscape
  2. Davis, R. M.; Matsumoto, S.; Bernardo, M.; Sowers, A.; Matsumoto, K. I.; Krishna, M. C.; Mitchell, J. B.
  3. Free Radical Biology and Medicine. 2011, Feb; 50(3): 459-468.
  1. 12.   Generation of HIV-1 primary isolates representative of plasma variants using the U87.CD4 cell line
  2. Heeregrave, E. J.; Ampofo, W. K.; Tetteh, J. K. A.; Ofori, M.; Ofori, S. B.; Shah, A. S.; Pollakis, G.; Paxton, W. A.
  3. Journal of Virological Methods. 2010, Nov; 169(2): 341-350.
  1. 13.   Bifunctional fusion proteins of the human engineered antibody domain m36 with human soluble CD4 are potent inhibitors of diverse HIV-1 isolates
  2. Chen, W. Z.; Xiao, X. D.; Wang, Y. P.; Zhu, Z. Y.; Dimitrov, D. S.
  3. Antiviral Research. 2010, Oct; 88(1): 107-115.
  1. 14.   Soluble TLT-1 modulates platelet-endothelial cell interactions and actin polymerization
  2. Morales, J.; Villa, K.; Gattis, J.; Castro, W.; Colon, K.; Lubkowski, J.; Sanabria, P.; Hunter, R.; Washington, A. V.
  3. Blood Coagulation & Fibrinolysis. 2010, Apr; 21(3): 229-236.
  1. 15.   Metal Ions-Stimulated Iron Oxidation in Hydroxylases Facilitates Stabilization of HIF-1 alpha Protein
  2. Kaczmarek, M.; Cachau, R. E.; Topol, I. A.; Kasprzak, K. S.; Ghio, A.; Salnikow, K.
  3. Toxicological Sciences. 2009 107(2): 394-403.
  1. 16.   Novel Human Interleukin-15 Agonists
  2. Zhu, X. Y.; Marcus, W. D.; Xu, W. X.; Lee, H. I.; Han, K. P.; Egan, J. O.; Yovandich, J. L.; Rhode, P. R.; Wong, H. C.
  3. Journal of Immunology. 2009 183(6): 3598-3607.
  1. 17.   Glycoside analogs of beta-galactosylceramide, a novel class of small molecule antiviral agents that inhibit HIV-1 entry
  2. Garg, H.; Francella, N.; Tony, K. A.; Augustine, L. A.; Barchi, J. J.; Fantini, J.; Puri, A.; Mootoo, D. R.; Blumenthal, R.
  3. Antiviral Research. 2008 80(1): 54-61.
  1. 18.   Effects of Manganese Superoxide Dismutase Silencing on Androgen Receptor Function and Gene Regulation: Implications for Castration-Resistant Prostate Cancer
  2. Sharifi, N.; Hurt, E. M.; Thomas, S. B.; Farrar, W. L.
  3. Clinical Cancer Research. 2008 14(19): 6073-6080.
  1. 19.   Mutations that alter the equilibrium between open and closed conformations of Escherichia coli maltose-binding protein impede its ability to enhance the solubility of passenger proteins
  2. Nallamsetty, S.; Waugh, D. S.
  3. Biochemical and Biophysical Research Communications. 2007, Dec; 364(3): 639-644.
  1. 20.   A covalent inhibitor targeting an intermediate conformation of the fusogenic subunit of the HIV-1 envelope complex
  2. Jacobs, A.; Quraishi, O.; Huang, X. C.; Bousquet-Gagnon, N.; Nault, G.; Francella, N.; Alvord, W. G.; Pham, N.; Soucy, C.; Robitaille, M.; Bridon, D.; Blumenthal, R.
  3. Journal of Biological Chemistry. 2007, Nov; 282(44): 32406-32413.
  1. 21.   NKT cell-derived urokinase-type plasminogen activator promotes peripheral tolerance associated with eye
  2. Sonoda, K. H.; Nakamura, T.; Young, H. A.; Hart, D.; Carmeliet, P.; Stein-Streilein, J.
  3. Journal of Immunology. 2007, Aug; 179(4): 2215-2222.
  1. 22.   Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study
  2. Purdue, M. P.; Lan, Q.; Kricker, A.; Grulich, A. E.; Vajdic, C. M.; Turner, J.; Whitby, D.; Chanock, S.; Rothman, N.; Armstrong, B. K.
  3. Carcinogenesis. 2007, Mar; 28(3): 704-712.
  1. 23.   Human defensins: synthesis and structural properties
  2. Pazgier, M.; Li, X.; Lu, W.; Lubkowski, J.
  3. Current Pharmaceutical Design. 2007 13(30): 3096-3118.
  1. 24.   Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors
  2. Yazawa, H.; Murakami, T.; Li, H. M.; Back, T.; Kurosaka, K.; Suzuki, Y.; Shorts, L.; Akiyama, Y.; Maruyama, K.; Parsoneault, E.; Wiltrout, R. H.; Watanabe, M.
  3. Cancer Gene Therapy. 2006, Nov; 13(11): 993-1001.
  1. 25.   Anti-HIV-1 immunotoxin 3B3(Fv)-PE38: enhanced potency against clinical isolates in human PBMCs and macrophages, and negligible hepatotoxicity in macaques
  2. Kennedy, P. E.; Bera, T. K.; Wang, Q. C.; Gallo, M.; Wagner, W.; Lewis, M. G.; Berger, E. A.; Pastan, I.
  3. Journal of Leukocyte Biology. 2006, Nov; 80(5): 1175-1182.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel